PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 2 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

20 July 2026

  1. (diff | hist) N 10:12 Asymchem Laboratories 1,789 +1,789 TrialsTabitha (talk | contribs) start organisation article — registry facts and product scope only
  2. (diff | hist) 05:48 Peptide stability table 6,886 ±0 SchemaSorcha (talk | contribs) add the assumed syringe scale to the readout label [rollback]
  3. (diff | hist) m 05:10 Injection site rotation 4,872 ±0 RotationRosalind (talk | contribs) expand §Lipohypertrophy [rollback]
  4. (diff | hist) 04:10 Growth hormone secretagogue 4,613 ±0 TB500_Tarquin (talk | contribs) add the year the sequence was first described, with the citation [rollback]
  5. (diff | hist) m 03:49 USP General Chapter 71 4,657 ±0 RepackRadek (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  6. (diff | hist) 02:06 Baseline laboratory panel 4,429 ±0 UACR_Ulric (talk | contribs) add the pre-analytical requirement: tube type and time to separation [rollback]
  7. (diff | hist) m 01:56 Active pharmaceutical ingredient 4,569 ±0 PharmDrafts (talk | contribs) state that the position differs between jurisdictions and give two examples [rollback]

19 July 2026

  1. (diff | hist) 23:19 Reconstitution calculator 8,662 ±0 RfC_Rasmus (talk | contribs) add the axis labels to the inline bar figure [rollback]
  2. (diff | hist) m 22:29 Retention time 4,104 ±0 DisparityDagny (talk | contribs) add the repeatability figure with the number of injections [rollback]
  3. (diff | hist) 21:12 Dose escalation schedule 4,993 ±0 ComparisonCato (talk | contribs) state the syringe graduation the unit figure assumes [rollback]
  4. (diff | hist) 20:55 Albumin binding half-life extension 6,399 ±0 ArcuateArt (talk | contribs) rm the sentence implying the hormone is a drug [rollback]
  5. (diff | hist) m b 20:41 Shanghai ERP Biotechnology 14,639 +2 CategoryBot (talk | contribs) bot: add supplier category [rollback]
  6. (diff | hist) 16:48 Batch number 4,573 ±0 TallySheetTad (talk | contribs) add the cross-link to the traceability article [rollback]
  7. (diff | hist) m b 15:43 Contraindications of incretin therapy 4,993 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  8. (diff | hist) 13:16 Vial filling and stoppering 4,833 ±0 ImageReuseIris (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  9. (diff | hist) 12:13 Crude peptide 4,775 ±0 SPPS_Sorrel (talk | contribs) de-orphan [rollback]
  10. (diff | hist) m b 08:51 Insulin syringe unit conversion 6,290 ±0 StubSorterBot (talk | contribs) bot: add stub category [rollback]
  11. (diff | hist) m 07:38 Cost per milligram 4,125 ±0 UnderfillUna (talk | contribs) add the year each price figure refers to [rollback]
  12. (diff | hist) m 07:09 Trial data comparison 7,303 ±0 GradientGus (talk | contribs) add the source for each stability figure in the table [rollback]
  13. (diff | hist) 06:49 Methionine oxidation 5,001 ±0 BalanceBirdie (talk | contribs) convert a hard-coded date to the house format [rollback]
  14. (diff | hist) 01:45 Glucagon 7,074 ±0 TSH_Tallulah (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]
  15. (diff | hist) 01:38 Peptide supply chain 8,410 ±0 EscalationEira (talk | contribs) close an unbalanced quotation mark [rollback]
  16. (diff | hist) 01:10 Third-party testing 7,489 ±0 BetaCellBoyd (talk | contribs) expand §Sampling and representativeness [rollback]
  17. (diff | hist) 01:05 GLP-1 receptor 7,570 ±0 AAA_Analyst (talk | contribs) add the citation for the co-secretion finding [rollback]

18 July 2026

  1. (diff | hist) m 23:22 Zhuhai Kerui Biotechnology 14,713 +2 Chromatokid (talk | contribs) consistent en dashes in ranges [rollback]
  2. (diff | hist) 20:26 Repackaging 4,759 ±0 FreightFenna (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  3. (diff | hist) 19:37 Weight regain after discontinuation 4,670 ±0 ClinicCorrespondent (talk | contribs) flag the section as needing a source for two remaining figures [rollback]
  4. (diff | hist) 19:35 High-performance liquid chromatography 7,231 ±0 Areapercent_Ayo (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) 18:36 Sharps disposal 20,876 ±0 UnitsUrsula (talk | contribs) de-orphan [rollback]
  6. (diff | hist) 18:33 Lixisenatide 4,195 ±0 LiraLotte (talk | contribs) reorder the analogues chronologically rather than alphabetically [rollback]
  7. (diff | hist) 17:01 Flourishglobal Peptide Biotech 14,773 +2 VerifyFirstVida (talk | contribs) British spelling per PP:MOS [rollback]
  8. (diff | hist) 15:06 Loss on drying 4,874 ±0 Chromatokid (talk | contribs) clarify that area percent is not mass percent [rollback]
  9. (diff | hist) m 14:52 FLOW trial 4,583 ±0 GradientGus (talk | contribs) add the year of publication to each trial in the list [rollback]
  10. (diff | hist) 13:40 GLP-1 receptor agonist 11,264 ±0 StateBoardStace (talk | contribs) expand §Molecular strategies for half-life extension [rollback]
  11. (diff | hist) 13:23 Chinese Peptide Company 15,515 +2 Retention_Time_Rae (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  12. (diff | hist) 12:44 Regulatory status by jurisdiction 4,444 ±0 GMP_Gita (talk | contribs) split the compounding position from the manufacturing position [rollback]
  13. (diff | hist) m 12:26 Peptide content 8,404 ±0 SurmountSurma (talk | contribs) rm the vendor name from a methodological sentence [rollback]
  14. (diff | hist) m 11:56 Personal importation policy 4,121 ±0 FigureFerdinand (talk | contribs) serial comma per PP:MOS [rollback]
  15. (diff | hist) 11:17 Medutest 5,018 ±0 VerifyVesna (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  16. (diff | hist) m 09:01 Aspiration risk under anaesthesia 4,681 ±0 SeeAlsoSelma (talk | contribs) add the contraindication with its rationale [rollback]
  17. (diff | hist) 07:08 Retatrutide 7,421 ±0 SPPS_Sorrel (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  18. (diff | hist) 05:33 Mass spectrometry 5,612 ±0 GIP_Genoveva (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  19. (diff | hist) m 05:21 Preparative HPLC purification 4,882 ±0 eGFR_Esme (talk | contribs) state that overlay gas is used and name it [rollback]
  20. (diff | hist) m 04:52 Peptide harm reduction 4,800 ±0 TierTwoTansy (talk | contribs) ce [rollback]
  21. (diff | hist) m 02:38 Qingdao Saber Technology Pharmaceutical 14,594 +2 VerifyVesna (talk | contribs) add the transit window each regional warehouse serves [rollback]
  22. (diff | hist) 02:05 Haemoglobin A1c 4,243 ±0 BaselineBex (talk | contribs) state the fasting requirement explicitly [rollback]
  23. (diff | hist) 01:52 Sangon Biotech 14,766 +2 PioneerPerdita (talk | contribs) expand §Product range [rollback]
  24. (diff | hist) 01:08 Xi'an Mokemei Biotechnology 15,423 +2 LedgerLysander (talk | contribs) space between number and unit per PP:MOS [rollback]
  25. (diff | hist) 00:08 Peptide aggregation 5,516 ±0 ChromCleanupCass (talk | contribs) add the sample preparation, since the result depends on it [rollback]

17 July 2026

  1. (diff | hist) m 22:58 GL Biochem (Shanghai) 16,491 ±0 PeakShapePol (talk | contribs) split §Operations from §Product range [rollback]
  2. (diff | hist) 21:25 Trifluoroacetate counterion 5,116 ±0 TechnicianTeal (talk | contribs) add the plate-count expression and define its terms [rollback]
  3. (diff | hist) m b 21:22 Reverse-phase HPLC 5,499 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) 20:07 Gastric emptying 5,565 ±0 AnalyticalAnnie (talk | contribs) expand §Interaction with oral drugs [rollback]
  5. (diff | hist) m 19:47 Dual incretin agonist 5,851 ±0 HalfLifeHavel (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  6. (diff | hist) m 19:28 Survodutide 5,445 ±0 CustomsClarke (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  7. (diff | hist) 18:50 Area percent purity 8,537 ±0 FmocFrancis (talk | contribs) expand §What area percent cannot see [rollback]
  8. (diff | hist) m 18:32 Triple agonist 4,269 ±0 ExenatideEzra (talk | contribs) de-duplicate a repeated sentence [rollback]
  9. (diff | hist) 17:02 WuXi TIDES 16,434 ±0 ChromCleanupCass (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  10. (diff | hist) m b 16:06 Cold chain 27,220 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  11. (diff | hist) 15:39 SUSTAIN trial programme 5,153 ±0 LeaderLoic (talk | contribs) expand §Structure of the programme [rollback]
  12. (diff | hist) 15:29 Chain of custody 5,157 ±0 SemaglutideSasha (talk | contribs) add the chain-of-custody point to §Limitations [rollback]
  13. (diff | hist) m 13:49 Multi-dose vial 24,688 ±0 AnalyticalAnnie (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  14. (diff | hist) 13:27 Arcuate nucleus 5,251 ±0 SPPS_Sorrel (talk | contribs) expand §Neuronal populations [rollback]
  15. (diff | hist) 12:15 Placebo-adjusted effect 4,805 ±0 StabilityStig (talk | contribs) split the results table so the two doses are separate rows [rollback]
  16. (diff | hist) 11:28 PeptideMeter 4,925 ±0 UnderfillUna (talk | contribs) add short description [rollback]
  17. (diff | hist) m b 10:43 Drug master file 4,325 ±0 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]
  18. (diff | hist) 03:58 Shanghai Wibson Biotechnology 15,442 +2 CoI_Corin (talk | contribs) split §Operations from §Product range [rollback]
  19. (diff | hist) m 03:26 Missed dose 5,277 ±0 SubQ_Solveig (talk | contribs) add a second worked example at a different vial strength [rollback]
  20. (diff | hist) m b 02:26 Tianjin Finder Chemical 14,451 +2 ArchiveBot (talk | contribs) bot: add supplier category [rollback]
  21. (diff | hist) m 01:53 Residual solvent 5,085 ±0 LOD_Lorcan (talk | contribs) expand §Classes and limits [rollback]
  22. (diff | hist) m 00:10 Peptide 6,813 ±0 SupplyWatchSuri (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]

16 July 2026

  1. (diff | hist) 22:52 Fmoc chemistry 4,618 ±0 Retention_Time_Rae (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  2. (diff | hist) 20:10 Timeline of incretin therapeutics 4,460 ±0 OrforglipronOona (talk | contribs) add the structural figure and caption it properly [rollback]
  3. (diff | hist) 17:30 Underfilling 4,882 ±0 EndpointEnid (talk | contribs) British spelling per PP:MOS [rollback]
  4. (diff | hist) 16:56 Amylin receptor agonist 5,245 ±0 ListMakerLumi (talk | contribs) expand §Analytical notes [rollback]
  5. (diff | hist) m 16:22 Dipeptidyl peptidase-4 7,022 ±0 BetaCellBoyd (talk | contribs) state that the enzyme inhibitor class works by raising endogenous levels [rollback]
  6. (diff | hist) m b 16:19 Analytical method validation 5,342 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  7. (diff | hist) m 15:03 Sterile water for injection 4,738 ±0 DrTitration (talk | contribs) add the sharps-disposal cross-link [rollback]
  8. (diff | hist) m 14:41 Nantong Guangyuan Chemical 15,116 +2 CrossRefCleve (talk | contribs) add the transit window each regional warehouse serves [rollback]
  9. (diff | hist) 13:12 VendorInvestigate 5,067 ±0 DiffWatchDov (talk | contribs) add the citation for the blind-sampling discussion [rollback]
  10. (diff | hist) m 12:05 Dulaglutide 5,490 ±0 ComparisonCato (talk | contribs) fix a dangling clause [rollback]
  11. (diff | hist) m b 11:23 Purity claim inflation 5,660 ±0 ArchiveBot (talk | contribs) bot: flag bare reference [rollback]
  12. (diff | hist) 09:45 USP General Chapter 85 5,180 ±0 GHK_Gwendolen (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  13. (diff | hist) 09:17 MOTS-c 4,670 ±0 EpitalonEoin (talk | contribs) add the note that lyophilised material is not sterile unless stated [rollback]
  14. (diff | hist) 09:07 Proglucagon 6,709 ±0 ReceptorRhoda (talk | contribs) expand §Gene and transcript [rollback]
  15. (diff | hist) m b 06:56 Reference standard 5,217 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  16. (diff | hist) m 06:13 Tirzepatide 8,037 ±0 LiraLotte (talk | contribs) the lead claimed weekly dosing for a compound dosed daily; corrected [rollback]
  17. (diff | hist) m 04:57 ISO 9001 4,278 ±0 FiveOhThreeB (talk | contribs) add the year the guidance was issued [rollback]
  18. (diff | hist) 04:42 SELECT trial 5,171 ±0 Chromatokid (talk | contribs) ce [rollback]
  19. (diff | hist) 04:35 SURMOUNT trial programme 5,021 ±0 HyphenHarriet (talk | contribs) sentence case in headings per PP:MOS [rollback]
  20. (diff | hist) m b 03:55 Reconstitution of lyophilised peptides 5,761 ±0 CiteBot (talk | contribs) bot: normalise unit spacing [rollback]
  21. (diff | hist) m b 03:02 SURPASS trial programme 5,078 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  22. (diff | hist) m b 02:45 Hypoglycaemia 4,473 ±0 StubSorterBot (talk | contribs) bot: expand PMID to full citation [rollback]
  23. (diff | hist) 01:54 Bacteriostatic water 4,652 ±0 CarryOverCai (talk | contribs) add the cross-link to the calculator page [rollback]
  24. (diff | hist) m 01:42 CagriSema 5,687 ±0 CuriousCallum (talk | contribs) attribute the mechanism claim to the review rather than stating it flatly [rollback]

15 July 2026

  1. (diff | hist) 23:57 Enteroendocrine L cell 5,083 ±0 HalfLifeHavel (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  2. (diff | hist) m b 23:29 Liraglutide 5,967 ±0 CiteBot (talk | contribs) bot: add drug-class category [rollback]
  3. (diff | hist) 22:24 Amylin 5,795 ±0 DulaglutideDug (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  4. (diff | hist) m 22:13 Customs seizure 4,785 ±0 AnalyticalAnnie (talk | contribs) add the citation for the regulatory action [rollback]
  5. (diff | hist) m 20:49 Sharps disposal 20,876 ±0 NurseNoteNessa (talk | contribs) expand §Hazard basis [rollback]